MSK Research Highlights, February 23, 2023
EurekAlert!,
New research fromMemorial Sloan Kettering Cancer Center (MSK)and theSloan Kettering Institute a hub for basic science and…
New research fromMemorial Sloan Kettering Cancer Center (MSK)and theSloan Kettering Institute a hub for basic science and…
- Researchers publish results of ‘OrexiCAR’ in the high impact peer-reviewed journal Blood - - CoImmune licensed technology…
- Researchers publish results of 'OrexiCAR' in the high impact peer-reviewed journal Blood - - CoImmune licensed technology…
DURHAM, N.C., Feb. 2, 2023 /PRNewswire/ -- CoImmune, Inc., a clinical stage immuno-oncology company working to redefine cancer…